Label analysis is key to educating patients about risks of vitamin A-containing supplements.

Increase in dietary supplement use in the United States suggests a great need for clinicians to be aware of the range of their quality parameters.

Dietary supplements can have side effects; interact with medications, food, or other supplements; or be unsafe.

Weaknesses in regulatory approaches to negligent misrepresentation claims about dietary supplements can have clinical and public health consequences.

Statutory limitations prevent the FDA from effectively regulating dietary supplements and have generated numerous calls for reform.

Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients.

Consider the origins of America’s cosmetic and supplement industry and the advertising practices that sustain it.

Dr Crystal M. Hayes joins Ethics Talk to discuss her article, coauthored with Dr Anu Manchikanti Gomez: “Alignment of Abolition Medicine With Reproductive Justice.”

Russyan Mark Mabeza joins Ethics Talk to discuss his article, coauthored with Betial Asmerom, Dr Rupinder Legha, and Vanessa Nuñez: “An Abolitionist Approach to Antiracist Medical Education.”

Dr Carmen Black joins Ethics Talk to discuss her article, coauthored with Drs Emma Lo and Keith Gallagher: “Community Mental Health Centers’ Roles in Depolicing Medicine.”